chimeric antigen receptor gene modified T cells Clinical Trials
2 recruitingDrug
Not Applicable2
Showing 1–2 of 2 trials
Recruiting
Not Applicable
CD30 CAR-T in the Treatment of CD30 Positive Relapsed/Refractory Lymphoma
Lymphoma, B-Cell
Shanxi Bethune Hospital15 enrolled1 locationNCT06850285
Recruiting
Not Applicable
A Novel CAR-T Combined Expression of IL-15 in the Treatment of Malignant Hematological Tumors
Lymphoma, Non-HodgkinAcute Lymphocytic LeukemiaRelapsed/Refractory Multiple Myeloma
Shanxi Bethune Hospital45 enrolled1 locationNCT06783816